Lab News

August 1, 2015

Tyler Klann is awarded an NIH Predoctoral Fellowship from the Duke Center for Biomolecular and Tissue Engineering. Congrats Tyler!

March 7, 2015

Lauren's paper on light-inducible CRISPR-based gene regulation is highlighted in Biotechniques.

February 27, 2015

The Muscular Dystrophy Association releases statements on our work using CRISPR/Cas9 technology for gene therapy for Duchenne muscular dystrophy here and here.

February 18, 2015

Dave's paper on correction of mutations that cause Duchenne muscular dystrophy with the CRISPR/Cas9 system is published in Nature Communications.  Read the associated press releases from the Duke School of Engineering and FierceBiotech.

February 9, 2015

Lauren's paper on light-inducible CRISPR/Cas9-based gene regulation is published in Nature Chemical Biology.  Read Pratt's release here.

January 12, 2015

We welcome Matt Gemberling, Ph.D. to the Gersbach Lab as a postdoctoral associate.

January 7, 2015

Welcome undergrads!  Aishu Ramamurthi and Sarina Madhavan join the lab as undergraduate research assistants.

January 5, 2015

The Gersbach Lab is part of a Duke team led by Tim Reddy to be awarded an NIH grant to decipher the Genomics of Gene Regulation.

December 17, 2014

Pratiksha’s paper, in collaboration with the Guilak Lab, on enhancing cartilage formation by induced pluripotent stem cells by manipulating cell cycle inhibitors is published in Tissue Engineering.

December 12, 2014

The Gersbach and Asokan Labs receive a Duke-UNC Clinical and Translational Science Award (CTSA) Consortium Collaborative Translational Research Grant to collaborate on developing in vivo genome editing technologies.

December 10, 2014

Ami’s paper on protein engineering of transcription factors to enhance genetic reprogramming is published in ACS Synthetic Biology.

December 1, 2014

Duke University licenses technology developed in the Gersbach Lab to Editas Medicine, a startup company focused on therapeutic genome engineering. Read the release from Editas,Duke, and others.